Repatriating Profits: Tax and Foreign Exchange Rules for Life Sciences Investors in Kenya

A foreign life sciences investor repatriating profits from Kenya often assumes the hard part is a foreign exchange approval process. It is not. Kenya has had no exchange control regime for three decades, and the real cost of repatriation sits in the tax code, not in any central bank gate, with one structural choice that changes when that cost is actually triggered.

There Is No Exchange Control Approval to Clear

The Central Bank of Kenya’s own Foreign Exchange Guidelines state that the responsibility for managing foreign exchange business was delegated to authorised foreign exchange dealers following repeal of the Exchange Control Act, effective 27 December 1995. In practice this means an ordinary dividend, profit, or capital transfer out of Kenya runs through a commercial bank acting as an authorised dealer, not through a central bank application. The dealer bank retains supporting documentation rather than seeking prior approval: for a dividend transfer, the Guidelines call for an audited balance sheet and profit and loss account, a directors’ resolution declaring the dividend, a certified shareholder list, and evidence that withholding tax has been paid. Transfers of US$10,000 or more require this kind of supporting documentation, and dealer banks separately file periodic reports with CBK on foreign exchange flows above set thresholds, but none of this is an investor-facing approval step. The two exceptions that do involve CBK approval, a cap on Kenyan residents investing abroad above US$500,000 and a formerly capped ceiling on foreign ownership of NSE-listed shares that has since been lifted, do not touch ordinary profit repatriation by a foreign investor at all.

The Foreign Investments Protection Act’s Guarantee Is Real but Largely a Backstop

The Foreign Investments Protection Act, Chapter 518 of the Laws of Kenya, still offers a formal repatriation guarantee: under section 7, the holder of a certificate of approved enterprise status may transfer out of Kenya, in approved foreign currency, after-tax profits including uncapitalised retained profits, the certified capital amount, and principal and interest on any loan specified in the certificate. Section 3 empowers the Cabinet Secretary to issue that certificate on application. Because exchange controls were abolished in 1995 and there is no general restriction on repatriation for the certificate to guarantee against, this functions less as an operational precondition and more as a statutory assurance an investor can point to, useful for financing conditions or investor-state dispute protection rather than something that needs to be obtained before a bank will process a transfer.

The Real Cost Is Withholding Tax, Not an FX Gate

The standard, non-treaty withholding tax rate on dividends paid to a non-resident is 15%, confirmed directly against KRA’s own current rate table and its official Withholding Income Tax rates publication. This is worth stating carefully because KRA’s own site is not internally consistent: a separate KRA blog post on the taxation of dividends states a lower 10% non-resident rate, which appears to be stale content left unupdated elsewhere on KRA’s own site. An investor or advisor should rely on KRA’s official rate table and published rate schedule, not every page on KRA’s own domain, and should independently confirm the applicable rate before filing. Where a double tax agreement applies, this rate can fall to 10% or lower, but the standard rate an investor without treaty protection faces is 15%. Management or professional fees paid to a non-resident carry a separate 20% withholding rate, relevant where an investment structure involves management fee flows alongside dividends.

Branch or Subsidiary Changes When the Tax Actually Bites

The Finance Act 2023 introduced section 7B of the Income Tax Act, which taxes a non-resident operating in Kenya through a permanent establishment on its repatriated income for the year, calculated under a formula based on the movement in net assets and net profit rather than on cash actually remitted. The rate is 15%, set out in the Third Schedule, and applies alongside a cut in the branch corporate tax rate from 37.5% to 30%, equalising it with the resident company rate, both effective 1 January 2024. The structural consequence is significant: a Kenyan branch is taxed on deemed repatriated profit whether or not it actually sends cash home, calculated automatically each year from its balance sheet movement, while a Kenyan-incorporated subsidiary’s 15% dividend withholding tax is triggered only when a dividend is actually declared. A subsidiary structure lets an investor defer the tax trigger simply by not declaring a dividend; a branch cannot defer in the same way. For a life sciences investor choosing between operating through a branch or incorporating a Kenyan subsidiary, this is a live structuring decision with real cash-timing consequences, not a technicality.

What This Means for Structuring Repatriation

An investor should stop treating foreign exchange approval as the obstacle to plan around, since none exists for ordinary profit repatriation, and instead model the actual 15% standard withholding tax cost, check whether an applicable double tax treaty reduces it, and weigh the branch-versus-subsidiary choice specifically for its effect on when tax is triggered rather than only on headline rate. A foreign investor certificate under the Foreign Investments Protection Act is worth obtaining as a formal backstop guarantee, but is not itself the thing standing between an investor and moving money out of Kenya.